Prognostic implications of chromosome 17p deletions in human medulloblastomas-Reference-Cited by-同舟云学术

Prognostic implications of chromosome 17p deletions in human medulloblastomas

Published:1995 Issue:1 Volume:24 Page:39-45
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neuro-Oncol

Author:

Batra Surinder K.,McLendon Roger E.,Koo Ja Seok,Castelino-Prabhu Shobha,Fuchs Herbert E.,Krischer Jeffrey P.,Friedman Henry S.,Bigner Darell D.,Bigner Sandra H.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Neurology,Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF01052657.pdf

Reference20 articles.

1. Cogen P, Dansehwar L, Metzgar AK, Edwards MS: Deletion mapping of the medulloblastoma locus on chromosome 17p. Genomics 8: 279?285, 1990

2. Cogen PH: Prognostic significance of molecular genetic markers in childhood brain tumors. Pediatr Neurosurg 17: 245?250, 1991?92

3. Bigner SH, Mark J, Friedman HS, Biegel JA, Bigner DD: Structural chromosomal abnormalities in human medulloblastoma. Cancer Genet Cytogenet 30: 91?101, 1988

4. Bigner SH, Mark J, Bigner DD: Cytogenetics of human brain tumors. Cancer Genet Cytogenet 47: 141?154, 1990

5. Biegel JA, Rorke LB, Packer RJ, Sutton LN, Schut L, Bonner L, Emanuel BS: Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system. Genes Chromosom Cancer 1: 139?147, 1989

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consequences of Chromosome Loss: Why Do Cells Need Each Chromosome Twice?;Cells;2022-05-03

2. Genome-wide characterization of human minisatellite VNTRs: population-specific alleles and gene expression differences;Nucleic Acids Research;2021-04-13

3. Genome-wide characterization of human minisatellite VNTRs: population-specific alleles and gene expression differences;2020-11-05

4. Whole genome analysis identifies the association of TP53 genomic deletions with lower survival in Stage III colorectal cancer;Scientific Reports;2020-03-19

5. Whole genome analysis identifies the association of TP53 genomic deletions with lower survival in Stage III colorectal cancer;2019-10-11